Featured Studies
Featured studies include only those currently recruiting participants. They are listed according to the date they were added to the ClinicalTrials.gov registry, with the most recent studies appearing first.
- Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease.
Evaluation study. Background: - Individuals who demonstrate symptoms of Alzheimer's disease, such as progressive memory loss, may be eligible to participate in National Institutes of Health research studies. Ages 45 and over. Location in Bethesda, MD.
- Regional Rates of Cerebral Protein Synthesis: Effects of Sleep and Memory Consolidation.
Evaluation study. Background: - The brain needs sleep to function normally, but the purpose of sleep is not understood. Ages 18-28. Location in Bethesda, MD.
- PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal Dementia.
Evaluation study. This study will use positron emission tomography (PET) imaging to measure a receptor in the brain that is involved in inflammation. Ages 35 and over. Location in Bethesda, MD.
- PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD).
Interventional study. The purpose of this protocol is to measure a receptor in the brain using positron emission tomography (PET) that is involved in inflammation. Ages 18-50. Locations in Baltimore, MD; Bethesda, MD.
Search ClinicalTrials.gov for other NIH studies on Alzheimer's Disease and Other Memory Disorders.
Related Information
Clinical Research at NIMH
- For opportunities to participate in NIMH research on the NIH campus, visit the patient recruitment Website. Travel and lodging assistance available.
